BETTER CELLS FOR BETTER THERAPIES
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Dec 2024)
What this means for you
Registered since 04 Sept 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86984029
- Registration number
- 5556215
- Mark type
- Stylized text
- Filed
- 08 Jan 2016
- Published for opposition
- 15 Nov 2016
- Registered
- 04 Sept 2018
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 042 — Scientific and technological services: Medical and clinical research and development for others in the field of stem cells; consulting services in the field of stem cell therapy research, disease model systems research, and drug discovery and development; medical laboratory research; research, namely, scientific research; medical and scientific research, namely, conducting pre-clinical and clinical trials
Owner
- Fate Therapeutics, Inc., San Diego, CA, US
- Fate Therapeutics, Inc., San Diego, CA, US
- Fate Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 06 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Dec 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 04 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 01 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Jul 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Jul 2018 — USE AMENDMENT FILED
- 30 Jul 2018 — DIVISIONAL PROCESSING COMPLETE
- 10 Jul 2018 — DIVISIONAL REQUEST RECEIVED
- 30 Jul 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jul 2018 — TEAS REQUEST TO DIVIDE RECEIVED
- 10 Jul 2018 — TEAS STATEMENT OF USE RECEIVED